United States · FDA National Drug Code directory
ESOMEPRAZOLE MAGNESIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-527_95dea6c3-8880-42b2-a2d4-8cf93629127e
- Product NDC
- 69097-527
- Form
- GRANULE, FOR SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- ESOMEPRAZOLE MAGNESIUM
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200324
- Source listing expiry
- 20261231
Source-listed ingredients
- ESOMEPRAZOLE MAGNESIUM — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 GRANULE, FOR SUSPENSION, EXTENDED RELEASE in 1 CARTON (69097-527-34) · 69097-527-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →